Class II
Ongoing
Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
Why: Lack of assurance of sterility.
- Company
- Houston Rx LLC
Houston, TX, United States - Reported
- Oct 21, 2026
- Recall started
- Sep 25, 2026
- Where sold
- Nationwide in the USA.
- Amount
- 64 vials
- Full product description
- Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
- Lots / codes affected
- Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.